W.O.M. World of Medicine AG

EANS-Adhoc: W.O.M. World of Medicine AG
9M Figures with slightly increased order backlog but decline in sales/Return on sales before taxes of 3% also realistic for full business year 2009/

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

9-month report

09.11.2009

Given the 9-month figures and a current outlook based on the October figures stock listed medical device manufacturer W.O.M. WORLD OF MEDICINE AG anticipates that this year`s development after the first nine months will also be carried forward in the fourth quarter 2009. This implies a reduction in sales for the year 2009 as a whole of approximately 15%, with a return on sales before taxes of 3%. This takes into account the weakening of the US dollar. The previous outlook expected sales at the level as 2008 and a return on sales before taxes of 6%.

Especially US sales were lower than expected. In the end of the 3rd quarter 2009, a slight increase in the volume of orders booked indicates tentative signs of recovery in the region. However, the sustainability of these signs and the pace at which a potential shift in trends is established by WORLD OF MEDICINE`s sales are still placed in question.

The complete 9-Month Report 2009 is available on November 10, 2009, 8.00 a.m. CET, at the following link:

www.world-of-medicine.com/wsc/pdf/wom/en/qr_9monthreport_2009_wom.pdf  

The Management Board

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke
Cell Phone: + 49 (0) 172 402 67 40
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / free trade



Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: